Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004327650 | SCV003993766 | uncertain significance | not specified | 2023-06-07 | criteria provided, single submitter | clinical testing | The c.2243T>A (p.I748N) alteration is located in exon 21 (coding exon 21) of the NCKAP1L gene. This alteration results from a T to A substitution at nucleotide position 2243, causing the isoleucine (I) at amino acid position 748 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005012857 | SCV005636868 | uncertain significance | Immunodeficiency 72 with autoinflammation | 2024-06-04 | criteria provided, single submitter | clinical testing |